Dr. Laura C. Cappelli is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine, Division of Rheumatology, and a faculty member of the Johns Hopkins Arthritis Center. She earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and fellowship in rheumatology at the Johns Hopkins Hospital. Dr. Cappelli earned an MHS in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Her primary research focus is rheumatologic adverse effects of cancer immunotherapy including the clinical characteristics, epidemiology, impact on patients, and biologic mechanisms of these adverse events. Her work involves collaborations with oncologists and laboratory investigators in rheumatology and oncology. Dr. Cappelli also co-chairs the Immune Related Toxicity Team at Johns Hopkins. In addition, she studies rheumatoid arthritis, focusing on patients with seronegative disease and on the use of autoantibodies as biomarkers.

Dr. Hummers is the Co-Director of the Johns Hopkins Scleroderma Center and her main clinical and research interests are in projecting the clinical course in scleroderma and in scleroderma mimics.

Dr. Kopplin is an Assistant Professor in the University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences and serves as the director of their Uveitis service. She completed her medical degree and doctorate in Genetics at Case Western Reserve University followed by ophthalmology residency at the Casey Eye Institute. Dr. Kopplin then completed uveitis fellowship training at the Casey Eye Institute and the Devers Eye Institute. Her research interests include the epidemiology and therapeutic treatments of inflammatory eye diseases. She also cohosts Headlight in the Fog, a podcast on inflammatory eye diseases.

As an Assistant Professor of Pediatrics at Harvard Medical School and an attending pediatric rheumatologist at Boston Children’s Hospital (BCH), I specialize in caring for children with complex autoimmune conditions and have developed innovative treatment algorithms for patients with immune dysregulation and macrophage activation syndrome. In addition, I conduct translational research regarding the loss of immunologic tolerance in pediatric rheumatologic disorders such as juvenile idiopathic arthritis (JIA).

Dr. Crofford is Wilson Family Chair in Medicine, Professor of Medicine and of Pathology, Microbiology and Immunology, and Division Chief of the Division of Rheumatology & Immunology.  Her research is focused on understanding inflammation, pain, and stress as mediators of rheumatic diseases.  In addition to her work in arthritis, she is an international leader in fibromyalgia research.  She has maintained active research support the National Institutes of Health, Rheumatology Research Foundation, Arthritis Foundation, and industry sources throughout her career.  More than 250 journal articles and book chapters have been published as a result of her research.  

Dr. Crofford is a past president of the American College of Rheumatology Research and Education Foundation (now the Rheumatology Research Foundation) and the executive committee of the Board of Directors for the American College of Rheumatology.  Other significant leadership positions include service on the American Board of Internal Medicine for Rheumatology and Advisory Council to the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.  Dr. Crofford is active as a clinical Rheumatologist and has been named one of America's Top Doctors and Best Doctors.

Lianne Gensler is a Professor of Medicine at the University of California, San Francisco. She is Director of the Spondyloarthritis clinic and research program and Director of the Rheumatology Fellowship Program.

Lisa Christopher-Stine, MD, is a Professor of Medicine and Neurology and the Co-Founder and Director of the Johns Hopkins Myositis Center. She joined the faculty of the Division of Rheumatology at The Johns Hopkins University in 2003. In addition, she serves as Co-Chair of the Institutional Review Board at the Johns Hopkins University, and she is one of 24 core faculty members to teach in the Johns Hopkins Medical School Colleges Advisory Program, which provides clinical skills instruction in the first year of medical school and continued career advising throughout all four years of medical school. As a clinician scientist, she utilizes the Myositis Database developed by her and her colleagues for which she is the Principal Investigator, currently numbering well over 3000 patients recruited worldwide. She has a strong interest in autoantibodies in myositis, statin myopathies, and patient-reported outcome measures in patients with inflammatory myopathies.

Dr. Lisa Criscione-Schreiber attended Duke University School of Medicine, then completed residency and fellowship at Duke University, serving as Chief rheumatology fellow before joining the Duke Rheumatology faculty in 2003. She completed a Master of Education degree from the University of Cincinnati in 2014. She is a Professor of Medicine at Duke University. 

Dr. Criscione-Schreiber was the Duke Rheumatology Program Director from 2008 until June 2022 (APD 2007 ‚Äì 08, Associate PD for Duke's Med-Peds rheumatology fellowship 2008 ‚Äì 22).  During her tenure as PD, 44 fellows graduated from Duke Rheumatology, and she stays in contact with most of them. As program director, her priority was to know fellows well and help them create a training experience to allow them meet their career goals. In addition to teaching and mentoring, her academic work in education primarily grew out of work with the program directors of the Carolinas Fellows Collaborative (CFC). Her Rheumatology Research Foundation Clinician Scholar Educator Award (2011 ‚Äì 14) project was to further develop and study the CFC Rheumatology objective structured clinical evaluation (OSCE). Her masters thesis, completed during the award period, focused on assessment in medical education. Dr. Criscione-Schreiber has mentored many residents and fellows through education-related academic projects. Several Duke fellowship graduates have focused on education in their careers, a few of whom are now program directors themselves, and mentored two recent fellowship graduates through their own CSE awards. At Duke, she was one of the inaugural mentors for the Education Scholars branch of the Departmental faculty development academy and led this branch for several years. She created education lab meetings across the Duke Department of Medicine to enhance training in education research methodology and encourage networking and collaboration. In 2020 she became the Vice Chair for Education in the Duke Department of Medicine. Taking on this new role led her to pass the baton of fellowship PD to a new leader in summer 2022.

As a member of the Carolinas Fellows Collaborative, her first academic project in education was co-writing goals and objectives for rheumatology learning activities. Based on this curriculum development work, she was invited to join the ACR taskforce on Rheumatology milestones, which composed Rheumatology curricular milestones and the ACR entrustable professional activities for training. This work led to her becoming a founding member of the curriculum subcommittee of the COTW, which she chaired from 2019 ‚Äì 22.  She has been involved in the CSE Advisory Board since her CSE award started, and chaired this group from 2016 ‚Äì 19. Prior to receiving this award, one of her proudest professional moments was being asked to present the Education Year in Review during the 2020 ACR Convergence.

Lisa G. Rider, MD, is Head of the Environmental Autoimmunity Group. Dr. Rider leads national and international consortia that evaluate and conduct a wide range of basic and clinical studies on juvenile and adult myositis. The mission of the Environmental Autoimmunity Group is to understand the mechanisms for the development of autoimmune diseases to extend healthy life and reduce the burdens of illness and disability. Rider has focused much of her work on autoimmune muscle diseases in children, conducting research on myositis autoantibodies, genetic and environmental risk factors, pathogenesis, disease assessment, and therapeutic trials.  She also co-established and is co-chair of the International Myositis Assessment and Clinical Studies Group (IMACS). She has received several awards of distinction, including the 2022 ACR Excellence in Investigative Mentoring Award.

Lisa Zickuhr is a clinician educator at Washington University School of Medicine, Division of Rheumatology, where she serves as the Associate Program Director for the Rheumatology Fellowship as well as Director of the Medicine Clerkship.  Clinically, she is interested in caring for patients with systemic lupus erythematosus, and she spends her academic time investigating methods to best teach and assess fellows' skills in virtual care as well as health equity and justice.